Healthy Transitions in Late Stage Kidney Disease
|ClinicalTrials.gov Identifier: NCT02085837|
Recruitment Status : Completed
First Posted : March 13, 2014
Last Update Posted : January 5, 2017
|Condition or disease||Intervention/treatment||Phase|
|Chronic Kidney Disease||Other: Education Other: Daily weight measurement and monitoring Other: Universal Dietary education Other: Medication review Other: Focused advanced directive program Other: Countdown to fistula program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||130 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||An Open Label Randomized Controlled Study to Compare the Impact of Patient Centered Nursing Services in Addition to a Nephrologist's Usual Patient Care With Usual Nephrologist's Care in Late Stage Chronic Kidney Disease Patients.|
|Study Start Date :||October 2013|
|Actual Primary Completion Date :||July 2014|
|Actual Study Completion Date :||January 2016|
Experimental: Healthy Transitions Group
Additional education will be provided by nurses to improve communication and reduce fragmentation of care.
Other: Daily weight measurement and monitoring
Monitor weight to avoid problems related to hypervolemia.
Other: Universal Dietary education
To improve diet and health
Other: Medication review
Medication will be reviewed by nurses to detect any discrepancies to reduce medication error.
Other: Focused advanced directive program
Education will be provided to increase awareness and encourage patients to have advanced directive.
Other: Countdown to fistula program
To reduce the number of patients starting dialysis with catheter in place, comprehensive stepwise intervention will be provided by nurses to ensure arterio-venous (AV) fistula placement in all appropriate patients, with coordinated follow up and failure recovery processes.
No Intervention: Usual Care Group
Usual care by nephrologist. No additional nursing support services will be provide to this group.
- Hospitalization rate [ Time Frame: 18 months ]Reduction in hospitalization rate in intervention group as compare to control group.
- Improve hemodialysis access rates [ Time Frame: 18 months ]Percentage of patients with AVF, AVG or catheters
- Home dialysis [ Time Frame: 18 months ]Increase choice of home dialysis as modality of treatment
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02085837
|United States, New York|
|Division of Kidney diseases and Hypertension|
|Great Neck, New York, United States, 11021|
|Principal Investigator:||Steven Fishbane, MD||Northwell Health|